Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-22-072745
Filing Date
2022-06-21
Accepted
2022-06-21 08:31:14
Documents
1
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2218796-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2218796-1_4aseq1.xml 4/A 4231
  Complete submission text file 0001104659-22-072745.txt   5712
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address
Callori Fred (Reporting) CIK: 0001843393 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37467 | Film No.: 221026191